Discover 1,166 paid clinical trials in Pittsburgh, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,166
Two Year Developmental Follow-up for PREMOD2 Trial (Premature Infants Receiving Milking or Delayed Cord Clamping)
for
Neurodevelopmental Abnormality
Location: Pittsburgh PA, Newark DE, Cincinnati OH, Chicago IL,
Sponsor: Sharp HealthCare
Sex: All
Age: 1 - 3
Code: NCT03476980
Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
for
Non-Muscle Invasive Bladder Urothelial Carcinoma,
Location: Pittsburgh PA, Monroeville PA, Washington PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06770582
Phase 2, Recruiting
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
for
Cervical Carcinoma, Human Papillomavirus Infection
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Pittsburgh PA, Morgantown WV, Frederick MD, Columbus OH,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase 3, Recruiting
ATEMPT 2.0: Adjuvant T-DM1 vs TH
for
Breast Cancer, HER2-positive Breast Cancer
Location: Pittsburgh PA, Columbus OH, Philadelphia PA,
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT04893109
Phase 2, Recruiting
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
for
Ovary Cancer, Peritoneal Cancer, Fallopian Tube Cancer
Location: Pittsburgh PA, Philadelphia PA, Chicago IL, Madison WI,
Sponsor: University of Colorado, Denver
Sex: Female
Age: 18 - 70+
Code: NCT05887609
Phase 2, Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,